Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by TScan Therapeutics, Inc. < Previous 1 2 Next > TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting September 27, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics to Participate in Upcoming Investor Conferences September 05, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME August 29, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 10, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Transition of Chief Financial Officer June 29, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors June 06, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting June 01, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Closing of Public Offering June 01, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics to Participate in the Jefferies Healthcare Conference June 01, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Pricing of $140 Million Public Offering May 26, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Launch of Proposed Public Offering May 25, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors May 24, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy 26th Annual Meeting May 17, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 10, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease May 09, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers AMGN TCRX TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting May 02, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors April 10, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces CEO Transition March 31, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces First Patient Dosed in Phase 1 Umbrella Clinical Trial Evaluating TSC-100 and TSC-101 for the Treatment of Hematologic Malignancies March 14, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics to Participate in the Barclays Global Healthcare Conference March 13, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones March 08, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference March 01, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference February 21, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors January 23, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress January 05, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022 December 12, 2022 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe December 01, 2022 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference November 22, 2022 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting November 11, 2022 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 09, 2022 From TScan Therapeutics, Inc. Via GlobeNewswire Tickers TCRX < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.